Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients
We aim to describe the characteristics of hepcidin, IL-6, and TNF-α levels in anaemia of lung cancer patients with operative tumour as well as to investigate the potential diagnostic capabilities of hepcidin in combination with IL-6, TNF-α, and acute phase proteins. We present a retrospective study...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-12-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/15/1/224 |
| _version_ | 1797626118262489088 |
|---|---|
| author | Katarzyna Wadowska Piotr Błasiak Adam Rzechonek Iwona Bil-Lula Mariola Śliwińska-Mossoń |
| author_facet | Katarzyna Wadowska Piotr Błasiak Adam Rzechonek Iwona Bil-Lula Mariola Śliwińska-Mossoń |
| author_sort | Katarzyna Wadowska |
| collection | DOAJ |
| description | We aim to describe the characteristics of hepcidin, IL-6, and TNF-α levels in anaemia of lung cancer patients with operative tumour as well as to investigate the potential diagnostic capabilities of hepcidin in combination with IL-6, TNF-α, and acute phase proteins. We present a retrospective study of 112 lung cancer patients (41 women and 71 men) who were surgically treated at the Lower Silesian Centre for Lung Diseases in Wroclaw, Poland. Serum blood samples were collected from all these patients prior to any surgical treatment and used to determine hepcidin, IL-6, TNF-α, SAA<sub>1</sub>, and CRP concentrations. Patients were also examined with a complete blood count several times during their hospitalization. The female and male groups were divided based on the occurrence of anaemia during their hospitalization. Patients who developed anaemia post-operatively had significantly lower hepcidin concentrations than non-anaemic patients (<i>p</i> = 0.000694 in females with ≥3 complete blood count examinations and <i>p</i> = 0.007905 in males with 2 complete blood count examinations), whereas patients with anaemia since hospital admission had higher hepcidin concentrations. We observed two hepcidin roles related to two cancer anaemia pathogeneses: (1) higher hepcidin concentrations in patients with anaemia since hospital admission (anaemia of inflammation) and (2) lower hepcidin concentrations in patients who developed anaemia after surgery (anaemia of iron deficiency). Our data support the role of hepcidin, IL-6, and TNF-α in cancer-related anaemia and provide diagnostic values for predicting post-operative anaemia in lung cancer patients. |
| first_indexed | 2024-03-11T10:05:56Z |
| format | Article |
| id | doaj.art-7db6c14682734a81ac987130c7e1f230 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-11T10:05:56Z |
| publishDate | 2022-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-7db6c14682734a81ac987130c7e1f2302023-11-16T15:03:19ZengMDPI AGCancers2072-66942022-12-0115122410.3390/cancers15010224Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer PatientsKatarzyna Wadowska0Piotr Błasiak1Adam Rzechonek2Iwona Bil-Lula3Mariola Śliwińska-Mossoń4Department of Medical Laboratory Diagnostics, Division of Clinical Chemistry and Laboratory Haematology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, PolandDepartment and Clinic of Thoracic Surgery, Faculty of Medicine, Wroclaw Medical University, Grabiszyńska 105, 53-439 Wroclaw, PolandDepartment and Clinic of Thoracic Surgery, Faculty of Medicine, Wroclaw Medical University, Grabiszyńska 105, 53-439 Wroclaw, PolandDepartment of Medical Laboratory Diagnostics, Division of Clinical Chemistry and Laboratory Haematology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, PolandDepartment of Medical Laboratory Diagnostics, Division of Clinical Chemistry and Laboratory Haematology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, PolandWe aim to describe the characteristics of hepcidin, IL-6, and TNF-α levels in anaemia of lung cancer patients with operative tumour as well as to investigate the potential diagnostic capabilities of hepcidin in combination with IL-6, TNF-α, and acute phase proteins. We present a retrospective study of 112 lung cancer patients (41 women and 71 men) who were surgically treated at the Lower Silesian Centre for Lung Diseases in Wroclaw, Poland. Serum blood samples were collected from all these patients prior to any surgical treatment and used to determine hepcidin, IL-6, TNF-α, SAA<sub>1</sub>, and CRP concentrations. Patients were also examined with a complete blood count several times during their hospitalization. The female and male groups were divided based on the occurrence of anaemia during their hospitalization. Patients who developed anaemia post-operatively had significantly lower hepcidin concentrations than non-anaemic patients (<i>p</i> = 0.000694 in females with ≥3 complete blood count examinations and <i>p</i> = 0.007905 in males with 2 complete blood count examinations), whereas patients with anaemia since hospital admission had higher hepcidin concentrations. We observed two hepcidin roles related to two cancer anaemia pathogeneses: (1) higher hepcidin concentrations in patients with anaemia since hospital admission (anaemia of inflammation) and (2) lower hepcidin concentrations in patients who developed anaemia after surgery (anaemia of iron deficiency). Our data support the role of hepcidin, IL-6, and TNF-α in cancer-related anaemia and provide diagnostic values for predicting post-operative anaemia in lung cancer patients.https://www.mdpi.com/2072-6694/15/1/224lung cancernon-small cell lung carcinomaanaemia of chronic diseaseanaemia of inflammationiron deficiency anaemiabiomarkers |
| spellingShingle | Katarzyna Wadowska Piotr Błasiak Adam Rzechonek Iwona Bil-Lula Mariola Śliwińska-Mossoń Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients Cancers lung cancer non-small cell lung carcinoma anaemia of chronic disease anaemia of inflammation iron deficiency anaemia biomarkers |
| title | Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients |
| title_full | Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients |
| title_fullStr | Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients |
| title_full_unstemmed | Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients |
| title_short | Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients |
| title_sort | hepcidin as a diagnostic biomarker in anaemic lung cancer patients |
| topic | lung cancer non-small cell lung carcinoma anaemia of chronic disease anaemia of inflammation iron deficiency anaemia biomarkers |
| url | https://www.mdpi.com/2072-6694/15/1/224 |
| work_keys_str_mv | AT katarzynawadowska hepcidinasadiagnosticbiomarkerinanaemiclungcancerpatients AT piotrbłasiak hepcidinasadiagnosticbiomarkerinanaemiclungcancerpatients AT adamrzechonek hepcidinasadiagnosticbiomarkerinanaemiclungcancerpatients AT iwonabillula hepcidinasadiagnosticbiomarkerinanaemiclungcancerpatients AT mariolasliwinskamosson hepcidinasadiagnosticbiomarkerinanaemiclungcancerpatients |